Dana Point, CA, United States of America

John C Rewcastle

This inventor holds 1 USPTO granted patent. Top assignee: Endocare, Inc.. Active years: 2004.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 64(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of John C. Rewcastle

Introduction

John C. Rewcastle is a notable inventor based in Dana Point, California. He has made significant contributions to the field of medical technology, particularly in the area of computer-guided surgery. His innovative approach aims to enhance surgical precision and patient outcomes.

Latest Patents

John C. Rewcastle holds a patent for a groundbreaking invention titled "Computer Guided Surgery for Prostatic Nerve Sparing." This computer system is designed to acquire and display images of a patient's prostate, assisting surgeons in accurately placing ablative elements. The system is equipped with software that determines the dimensions of the prostate and identifies a treatment zone that includes only one neurovascular bundle, thereby minimizing adverse effects on the patient's sexual function. He has 1 patent to his name.

Career Highlights

Rewcastle's career is marked by his work at Endocare, Inc., where he has been instrumental in developing advanced surgical technologies. His dedication to improving surgical techniques has positioned him as a key figure in the medical device industry.

Collaborations

Throughout his career, John has collaborated with esteemed colleagues such as Jay J. Eum and Jawahar M. Ali. These partnerships have fostered innovation and contributed to the advancement of medical technology.

Conclusion

John C. Rewcastle's contributions to computer-guided surgery exemplify the impact of innovation in the medical field. His work continues to influence surgical practices and improve patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…